ImplemeNtation oF demOnstration pRoject for Health systeMs: Atrial Fibrillation (INFORM-AF) Part 1
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Atrial Fibrillation
- Sponsor
- Duke University
- Enrollment
- 52
- Locations
- 1
- Primary Endpoint
- Perceptions of using anticoagulation as a stroke prevention therapy in atrial fibrillation, as measured by survey and interview
- Status
- Completed
- Last Updated
- 9 years ago
Overview
Brief Summary
The goal of this study is to learn about the patient and provider perceptions, priorities, preferences, and willingness to use/prescribe anticoagulation as a stroke prevention therapy in patients with atrial fibrillation. Qualitative interviews will be performed with atrial fibrillation patients and providers caring for atrial fibrillation patients. The investigators want to understand the factors that influence decision-making about anticoagulation medications, and to gain insight into patients' and providers' knowledge of the risk of stroke and bleeding associated with oral anticoagulation. This feedback will help provide better education to providers caring for patients with atrial fibrillation and better care to patients with atrial fibrillation by developing tools to optimize the appropriate use of oral anticoagulation for patients with atrial fibrillation.
Investigators
Eligibility Criteria
Inclusion Criteria
- •adult patient age 18 or older;
- •English speaking;
- •diagnosed atrial fibrillation;
- •at least 1 risk factor for congestive heart failure, hypertension, age, diabetes, stroke (CHADS2) or 2 risk factors for CHADS2 with vascular disease, age, and sex (CHADS2-VASc) ;
- •no documented cognitive impairment per the medical record;
- •not being prescribed an oral anticoagulant
- •Provider Inclusion Criteria:
- •physician at one of the study sites treating patients diagnosed with atrial fibrillation
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Perceptions of using anticoagulation as a stroke prevention therapy in atrial fibrillation, as measured by survey and interview
Time Frame: one hour
Each telephone interview (data collection time point) will be approximately one hour
Secondary Outcomes
- Willingness to use anticoagulation as a stroke prevention therapy in atrial fibrillation, as measured by survey and interview(one hour)
- priorities for using anticoagulation as a stroke prevention therapy in atrial fibrillation, as measured by survey and interview(one hour)
- preferences for using anticoagulation as a stroke prevention therapy in atrial fibrillation, as measured by survey and interview(one hour)